RECURRENT ESOPHAGEAL CARCINOMA
Clinical trials for RECURRENT ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough esophageal cancer
Disease control OngoingThis study tests whether adding the drug cixutumumab to standard chemotherapy (paclitaxel) can help people with esophageal cancer that has spread. About 94 adults with metastatic esophageal or gastroesophageal junction cancer will receive either paclitaxel alone or paclitaxel plu…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC